American Journal of Cardiology
Volume 105, Issue 8 , Pages 1076-1082, 15 April 2010

Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention

  • Michael S. Lee, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
    • Corresponding Author InformationCorresponding author: Tel: (301) 696-9523; fax: 310-206-3607
  • ,
  • Tae Yang, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
  • ,
  • David E. Kandzari, MD

      Affiliations

    • Division of Cardiology, Scripps Clinic, La Jolla, California
  • ,
  • Jonathan M. Tobis, MD

      Affiliations

    • Division of Cardiology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California
  • ,
  • Hsini Liao, PhD

      Affiliations

    • Boston Scientific Corporation, Natick, Massachusetts
  • ,
  • Ehtisham Mahmud, MD

      Affiliations

    • Division of Cardiology, University of California, San Diego, School of Medicine, San Diego, California

Received 2 October 2009; received in revised form 3 December 2009; accepted 3 December 2009. published online 22 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Lee is a member of the Speaker's Bureau for Schering-Plough, Kenilworth, New Jersey, Boston Scientific Corporation, Boston, Massachusetts, and Bristol-Myers Squibb, New York, New York. Dr. Tobis is a member of the Speaker's Bureau for Boston Scientific Corporation, Boston, Massachusetts. Dr. Mahmud has received research grants for clinical trials from Boston Scientific, Boston, Massachusetts, and Abbott Vascular, and is on the Speakers List for Medtronic. Dr. Kandzari has received research grant support from Medtronic, Santa Rosa, California, and is a consultant to Cordis, Johnson & Johnson, Warren, New Jersey. Dr. Liao is an employee of Boston Scientific Corporation, Boston, Massachusetts.

PII: S0002-9149(09)02834-3

doi:10.1016/j.amjcard.2009.12.006

American Journal of Cardiology
Volume 105, Issue 8 , Pages 1076-1082, 15 April 2010